{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:08:35Z","timestamp":1787069315686,"version":"build-2736575974"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"am","delay-in-days":270,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mitochondrion"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.mito.2024.101905","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T12:35:17Z","timestamp":1716554117000},"page":"101905","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["ACAD9 treatment with bezafibrate and nicotinamide riboside temporarily stabilizes cardiomyopathy and lactic acidosis"],"prefix":"10.1016","volume":"78","author":[{"given":"Johan L.K.","family":"Van Hove","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa W.","family":"Friederich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6940-4420","authenticated-orcid":false,"given":"Daniella H.","family":"Hock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2048-3383","authenticated-orcid":false,"given":"David A.","family":"Stroud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0817-1686","authenticated-orcid":false,"given":"Nikeisha J.","family":"Caruana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7297-147X","authenticated-orcid":false,"given":"Uwe","family":"Christians","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Schniedewind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cole R.","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3162-0571","authenticated-orcid":false,"given":"Richard","family":"Reisdorph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin D.J.","family":"Lopez Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4955-3226","authenticated-orcid":false,"given":"Charles","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonia E.","family":"Donovan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica C.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn C.","family":"Chatfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin A.","family":"Larson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"Peter R.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5719-1520","authenticated-orcid":false,"given":"Shawn E.","family":"McCandless","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan F.","family":"Moore Burk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mito.2024.101905_b0005","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1210\/jc.2007-1701","article-title":"Activation of peroxisome proliferator-activated receptor pathway stimulates the mitochondrial respiratory chain and can correct deficiencies in patients\u2019 cells lacking its components","volume":"93","author":"Bastin","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mito.2024.101905_b0010","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev.med.53.082901.104018","article-title":"The mechanism of action of PPARs","volume":"53","author":"Berger","year":"2002","journal-title":"Annu. Rev. Med."},{"issue":"4","key":"10.1016\/j.mito.2024.101905_b0015","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0092-8674(04)00416-7","article-title":"Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-Handler independent route to NAD+ in fungi and humans","volume":"117","author":"Bieganoski","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.mito.2024.101905_b0020","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1056\/NEJMc0806334","article-title":"Bezafibrate for an inborn mitochondrial beta-oxidation defect","volume":"360","author":"Bonnefont","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mito.2024.101905_b0025","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/clpt.2010.55","article-title":"Long-term follow-up of bezafibrate treatment in patients with the myopathic form of carnitine palmitoyltransferase 2 deficiency","volume":"88","author":"Bonnefont","year":"2010","journal-title":"Clin. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.mito.2024.101905_b0030","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3390\/antiox12020376","article-title":"NAD+ homeostasis and NAD+-consuming enzymes: implications for vascular health","volume":"12","author":"Campagna","year":"2023","journal-title":"Antioxidants (basel)"},{"key":"10.1016\/j.mito.2024.101905_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mito.2014.12.005","article-title":"Mitochondrial energy failure in HSD10 disease is due to defective mtDNA transcript processing","volume":"21","author":"Chatfield","year":"2015","journal-title":"Mitochondrion"},{"issue":"20","key":"10.1016\/j.mito.2024.101905_b0040","doi-asserted-by":"crossref","first-page":"5055","DOI":"10.3390\/ijms20205055","article-title":"Exploration and development of PPAR modulators in health and disease: an update of clinical evidence","volume":"20","author":"Cheng","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mito.2024.101905_b0045","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/ejhg.2015.264","article-title":"High incidence and variable clinical outcome of cardiac hypertrophy due to ACAD9 mutations in childhood","volume":"24","author":"Collet","year":"2016","journal-title":"Eur. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.mito.2024.101905_b0050","doi-asserted-by":"crossref","first-page":"9772","DOI":"10.1038\/s41598-019-46120-z","article-title":"Safety and metabolism of long-term administration of NIAGEN (nicotinamide riboside chloride) in a randomized, double-blind, placebo-controlled clinical trial of healthy overweight adults","volume":"9","author":"Conze","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mito.2024.101905_b0055","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1136\/jmedgenet-2015-103049","article-title":"Mutations in the mitochondrial cysteinyl-tRNA synthase gene, CARS2, lead to a severe epileptic encephalopathy and complex movement disorder","volume":"52","author":"Coughlin","year":"2015","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.mito.2024.101905_b0060","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ymgme.2016.05.005","article-title":"Evidence of a wide spectrum of cardiac involvement due to ACAD9 mutations: report on nine patients","volume":"118","author":"Dewulf","year":"2016","journal-title":"Mol. Genet. Metab."},{"issue":"21","key":"10.1016\/j.mito.2024.101905_b0065","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1161\/CIRCULATIONAHA.116.026099","article-title":"Nicotinamide riboside preserves cardiac function in a mouse model of dilated cardiomyopathy","volume":"137","author":"Diguet","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.mito.2024.101905_b0070","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.cmet.2011.11.003","article-title":"Species differences in the effects of bezafibrate as a potential treatment of mitochondrial disorders","volume":"14","author":"Djouadi","year":"2011","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.mito.2024.101905_b0075","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3390\/cells8040289","article-title":"Mitochondrial genetic disorders: cell signaling and pharmacological therapies","volume":"8","author":"Djouadi","year":"2019","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.mito.2024.101905_b0080","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000526022","article-title":"Severe antenatal hypertrophic cardiomyopathy secondary to ACAD9-related mitochondrial complex I deficiency","volume":"14","author":"Dubucs","year":"2023","journal-title":"Mol Syndromol"},{"issue":"7","key":"10.1016\/j.mito.2024.101905_b0085","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.celrep.2019.07.043","article-title":"Nicotinamide riboside augments the aged human skeletal muscle NAD+ metabolome and induces transcriptomic and anti-inflammatory signatures","volume":"28","author":"Elhassan","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.mito.2024.101905_b0090","unstructured":"European Medicines Agency. Assessment report for fenofibrate, bezafibrate, ciprofibrate, and gemfibrozil containing medicinal products. 28 February 2011. Accessed on 3\/8\/2022 at https:\/\/www.ema.europa.eu\/en\/medicines\/human\/referrals\/fibrates#all-documents-section."},{"issue":"3","key":"10.1016\/j.mito.2024.101905_b0095","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.ijcard.2014.11.014","article-title":"Cardiac manifestations of primary mitochondrial disorders","volume":"177","author":"Finsterer","year":"2014","journal-title":"Int. J. Cardiol."},{"issue":"3","key":"10.1016\/j.mito.2024.101905_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107541","article-title":"Dissecting the roles of mitochondrial complex I intermediate assembly complex factors in the biogenesis of complex I","volume":"31","author":"Formosa","year":"2020","journal-title":"Cell Rep."},{"issue":"17","key":"10.1016\/j.mito.2024.101905_b0105","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa2036205","article-title":"A randomized, controlled trial of the pan-PPAR agonist lanifibranor in NASH","volume":"385","author":"Francque","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"10.1016\/j.mito.2024.101905_b0110","doi-asserted-by":"crossref","first-page":"5386","DOI":"10.1074\/jbc.R117.809194","article-title":"Mitochondrial energy generation disorders: genes, mechanisms and clues to pathology","volume":"294","author":"Frazier","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mito.2024.101905_b0115","first-page":"702","article-title":"Mutations in the accessory subunit NDUFB10 result in isolated complex I deficiency and illustrate the critical role of intermembrane space import for complex I holoenzyme assembly","volume":"26","author":"Friederich","year":"2017","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.mito.2024.101905_b0120","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ymgme.2019.12.013","article-title":"Pathogenic variants in NUBPL result in failure to assemble the matrix arm of complex I and cause a complex leukoencephalopathy with thalamic involvement","volume":"129","author":"Friederich","year":"2020","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.mito.2024.101905_b0125","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/brain\/awq273","article-title":"Riboflavin-responsive oxidative phosphorylation complex I deficiency caused by defective ACAD9: new function for an old gene","volume":"134","author":"Gerards","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.mito.2024.101905_b0130","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1161\/01.RES.0000060700.55247.7C","article-title":"Peroxisome proliferator-activated receptor (PPAR) \u03b1 and PPAR\u03b2\/\u03b4, but not PPAR\u03b3, modulate the expression of genes involved in cardiac lipid metabolism","volume":"92","author":"Gilde","year":"2003","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.mito.2024.101905_b0135","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.tox.2007.09.030","article-title":"PPARalpha: mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators","volume":"246","author":"Gonzalez","year":"2008","journal-title":"Toxicology"},{"key":"10.1016\/j.mito.2024.101905_b0140","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.mito.2021.05.002","article-title":"Optic neuropathy linked to ACAD9 pathogenic variants: a potentially riboflavin-responsive disorder?","volume":"59","author":"Gueguen","year":"2021","journal-title":"Mitochondrion"},{"key":"10.1016\/j.mito.2024.101905_b0145","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1136\/jmedgenet-2012-100846","article-title":"Molecular diagnosis in mitochondrial complex I deficiency using exome sequencing","volume":"49","author":"Haack","year":"2012","journal-title":"J. Med. Genet."},{"issue":"12","key":"10.1016\/j.mito.2024.101905_b0150","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/ng.706","article-title":"Exome sequencing identifies ACAD9 mutations as a cause of complex I deficiency","volume":"42","author":"Haack","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mito.2024.101905_b0155","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1136\/jmedgenet-2012-100846","article-title":"Molecular diagnosis in mitochondrial complex I deficiency using exome sequencing","volume":"49","author":"Haack","year":"2012","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.mito.2024.101905_b0160","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1086\/519219","article-title":"A new genetic disorder in mitochondrial fatty acid \u03b2-oxidation: ACAD9 deficiency","volume":"81","author":"He","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.mito.2024.101905_b0165","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ymgme.2010.12.005","article-title":"Identification and characterization of new long chain acyl-CoA dehydrogenases","volume":"102","author":"He","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.mito.2024.101905_b0170","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1021\/jm030631e","article-title":"Peroxisome proliferator-activated receptor \u03b1\/\u03b3dual agonists for the treatment of type 2 diabetes","volume":"47","author":"Henke","year":"2004","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.mito.2024.101905_b0175","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/HEP.0000000000000395","article-title":"Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study","volume":"78","author":"Hirschfield","year":"2023","journal-title":"Hepatol"},{"key":"10.1016\/j.mito.2024.101905_b0180","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ijcard.2019.01.017","article-title":"Cardiomyopathy in children with mitochondrial disease: prognosis and genetic background","volume":"279","author":"Imai-Okazaki","year":"2019","journal-title":"Int. J. Cardiol."},{"issue":"10","key":"10.1016\/j.mito.2024.101905_b0185","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1515\/jpem-2019-0205","article-title":"Successful treatment of infantile-onset ACAD9-related cardiomyopathy with a combination of sodium pyruvate, beta-blocker, and coenzyme Q10","volume":"32","author":"Kadoya","year":"2019","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.mito.2024.101905_b0190","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.3390\/antiox12081523","article-title":"Functional and structural insights into the human PPAR\u03b1\/\u03b4\/\u03b3 targeting preferences of anti-NASH investigational drugs, lanifibranor, seladelpar, and elafibranor","volume":"12","author":"Kamata","year":"2023","journal-title":"Antioxidants"},{"issue":"10","key":"10.1016\/j.mito.2024.101905_b0195","doi-asserted-by":"crossref","first-page":"e13334","DOI":"10.1111\/eci.13334","article-title":"Implications of NAD+ boosters in translational medicine","volume":"50","author":"Kang","year":"2020","journal-title":"Eur. J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.mito.2024.101905_b0200","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000492875","article-title":"Targeting peroxisome proliferator activated receptor \u03b1 (PPAR \u03b1) for the prevention of mitochondrial impairment and hypertrophy in cardiomyocytes","volume":"49","author":"Kar","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.mito.2024.101905_b0205","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s42255-019-0161-5","article-title":"NAD+ homeostasis in health and disease","volume":"2","author":"Katsyuba","year":"2020","journal-title":"Nat Metab"},{"issue":"6","key":"10.1016\/j.mito.2024.101905_b0210","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/emmm.201403943","article-title":"Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3","volume":"6","author":"Khan","year":"2014","journal-title":"EMBO Mol. Med."},{"issue":"6","key":"10.1016\/j.mito.2024.101905_b0215","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.echo.2009.03.003","article-title":"Age specific reference intervals for indexed left ventricular mass in children","volume":"22","author":"Khoury","year":"2009","journal-title":"J. Am. Soc. Echocardiogr."},{"issue":"9","key":"10.1016\/j.mito.2024.101905_b0220","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa2306185","article-title":"Efficacy and safety of elafibranor in primary biliary cholangitis","volume":"390","author":"Kowdley","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.mito.2024.101905_b0225","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41525-021-00277-7","article-title":"Oligonucleotide correction of an intronic TIMMDC1 variant in cells of patients with severe neurodegenerative disorder","volume":"7","author":"Kumar","year":"2022","journal-title":"NPJ Genom. Med."},{"key":"10.1016\/j.mito.2024.101905_b0230","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.humpath.2015.09.039","article-title":"Neonatal multiorgan failure due to ACAD9 mutation and complex I deficiency with mitochondrial hyperplasia in liver, cardiac myocytes, skeletal muscle and renal tubules","volume":"46","author":"Leslie","year":"2016","journal-title":"Hum. Pathol."},{"issue":"1","key":"10.1016\/j.mito.2024.101905_b0235","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/s41467-018-03421-7","article-title":"Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults","volume":"9","author":"Martens","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mito.2024.101905_b0240","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2165\/00003495-198733060-00002","article-title":"Bezafibrate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hyperlipidemia","volume":"33","author":"Monk","year":"1987","journal-title":"Drugs"},{"key":"10.1016\/j.mito.2024.101905_b0245","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.cmet.2010.08.002","article-title":"Acyl-CoA dehydrogenase 9 is required for the biogenesis of oxidative phosphorylation complex I","volume":"12","author":"Nouws","year":"2010","journal-title":"Cell Metab."},{"key":"10.1016\/j.mito.2024.101905_b0250","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/8904_2013_242","article-title":"A patient with complex I deficiency caused by a novel ACAD9 mutation not responding to riboflavin treatment","volume":"12","author":"Nouws","year":"2014","journal-title":"JIMD Rep"},{"issue":"5","key":"10.1016\/j.mito.2024.101905_b0255","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/hmg\/ddt521","article-title":"ACAD9, a complex I assembly factor with a moonlighting function in fatty acid oxidation deficiencies","volume":"23","author":"Nouws","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mito.2024.101905_b0260","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1212\/WNL.0000000000000118","article-title":"Bezafibrate in skeletal muscle fatty acid oxidation disorders. A Randomized Clinical Trial","volume":"82","author":"\u00d8rngreen","year":"2014","journal-title":"Neurol"},{"issue":"6","key":"10.1016\/j.mito.2024.101905_b0265","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.cmet.2020.04.008","article-title":"Niacin cures systemic NAD+ deficiency and improves muscle performance in adult-onset mitochondrial myopathy","volume":"31","author":"Pirinen","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.mito.2024.101905_b0270","unstructured":"Product monograph, BEZALIP\u00ae SR, Allergan Inc., October 31, 2019. Accessed on the internet on 3\/7\/2023 at https:\/www.miravohealthcare.com\/wp-content\/uploads\/2020\/11\/Bezalip-ENG-400mg-PM-Nov-2019-.pdf and at https:\/\/pdf.hres.ca\/dpd_pm\/00053820.pdf."},{"key":"10.1016\/j.mito.2024.101905_b0275","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1016\/S0140-6736(18)30727-X","article-title":"Mitochondrial medicine in the omics era","volume":"391","author":"Rahman","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.mito.2024.101905_b0280","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13023-018-0784-8","article-title":"Clinical, biochemical and genetic spectrum of 70 patients with ACAD9 deficiency: is riboflavin supplementation effective?","volume":"13","author":"Repp","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"issue":"7","key":"10.1016\/j.mito.2024.101905_b0285","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.bbabio.2016.02.012","article-title":"Mitochondrial complex I-linked disease","volume":"1857","author":"Rodenburg","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mito.2024.101905_b0290","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.cmet.2014.08.001","article-title":"A SIRT7-dependent acetylation switch of GABP\u03b21 controls mitochondrial function","volume":"20","author":"Ryu","year":"2014","journal-title":"Cell Metab."},{"issue":"11","key":"10.1016\/j.mito.2024.101905_b0295","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1093\/hmg\/ddv074","article-title":"Complex I assembly function and fatty acid oxidation enzyme activity of ACAD9 both contributes to disease severity in ACAD9 deficiency","volume":"24","author":"Schiff","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mito.2024.101905_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115433","article-title":"Peroxisome proliferator-activated receptor (PPAR) agonists as a potential therapy for inherited metabolic disorders","volume":"209","author":"Seminotti","year":"2023","journal-title":"Biochem. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.mito.2024.101905_b0305","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ymgme.2021.09.002","article-title":"Development and characterization of a mouse model of Acad9 deficiency","volume":"134","author":"Sinsheimer","year":"2021","journal-title":"Mol. Genet. Metab."},{"issue":"14","key":"10.1016\/j.mito.2024.101905_b0310","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.jacc.2018.12.087","article-title":"Cardioprotective effect of the mitochondrial unfolded protein response during chronic pressure overload","volume":"73","author":"Smyrnias","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.mito.2024.101905_b0315","doi-asserted-by":"crossref","first-page":"e11589","DOI":"10.15252\/emmm.201911589","article-title":"Metabolic effects of bezafibrate in mitochondrial disease","volume":"12","author":"Steele","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.mito.2024.101905_b0320","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1475-2840-4-14","article-title":"Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lesson","volume":"4","author":"Tenebaum","year":"2005","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.mito.2024.101905_b0325","doi-asserted-by":"crossref","first-page":"e201301012","DOI":"10.5936\/csbj.201301012","article-title":"Targeted, LCMS-based metabolomics for quantitative measurement of NAD(+) metabolites","volume":"4","author":"Trammell","year":"2013","journal-title":"Comput. Struct. Biotechnol."},{"key":"10.1016\/j.mito.2024.101905_b0330","doi-asserted-by":"crossref","first-page":"12948","DOI":"10.1038\/ncomms12948","article-title":"Nicotinamide riboside is uniquely and orally bioavailable in mice and humans","volume":"7","author":"Trammell","year":"2016","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.mito.2024.101905_b0335","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1210\/clinem\/dgac528","article-title":"Premature ovarian insufficiency in CLPB deficiency: transcriptomic, proteomic and phenotypic insights","volume":"107","author":"Tucker","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mito.2024.101905_b0340","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1203\/00006450-200111000-00020","article-title":"Blue native polyacrylamide gel electrophoresis: a powerful tool in diagnosis of oxidative phosphorylation defects","volume":"50","author":"Van Coster","year":"2001","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.mito.2024.101905_b0345","unstructured":"Van Hove, J.L.K., Friederich, M.W., Strode, D.K., Van Hove, R.A., Miller, K., Sharma, R., Shah, H., Estrella, J., Gabel. L., Horslen, S., Kohli, R., Lovell, M.A., Molleston, J., Romero, R., Squires, J., Squires, R., Sundaram, S., Magee, J., Sokol, R., on behalf of the Childhood Liver Disease Research Network (ChiLDReN), 2024. Analysis of protein biomarkers to identify mitochondrial hepatopathies from other liver diseases. Hepatol. Commun., 8(1), e0361."},{"key":"10.1016\/j.mito.2024.101905_b0350","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cmet.2011.04.011","article-title":"In vivo correction of COX deficiency by activation of the AMPK\/PGC-1\u03b1 axis","volume":"14","author":"Viscomi","year":"2011","journal-title":"Cell Metab."},{"issue":"10","key":"10.1016\/j.mito.2024.101905_b0355","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.bbabio.2007.07.008","article-title":"Human mitochondrial complex I assembly: a dynamic and versatile process. 2007","volume":"1767","author":"Vogel","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mito.2024.101905_b0360","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.cmet.2008.07.006","article-title":"Activation of the PPAR-PGC-1\u03b1 pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype","volume":"8","author":"Wenz","year":"2008","journal-title":"Cell Metab."},{"issue":"6","key":"10.1016\/j.mito.2024.101905_b0365","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/hep4.1057","article-title":"The new generation pan-peroxisome proliferator-activated receptor agonist IVA337 protects the liver from metabolic disorders and fibrosis","volume":"1","author":"Wettstein","year":"2017","journal-title":"Hepatol Commun"},{"issue":"10","key":"10.1016\/j.mito.2024.101905_b0370","doi-asserted-by":"crossref","first-page":"103153","DOI":"10.1016\/j.isci.2021.103153","article-title":"Molecular mechanism of interactions between ACAD9 and binding partners in mitochondrial respiratory complex I assembly","volume":"24","author":"Xia","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.mito.2024.101905_b0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115510","article-title":"Design, synthesis and anti-NASH effect evaluation of novel GFT505 derivatives in vitro and in vivo","volume":"257","author":"Xiang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.mito.2024.101905_b0380","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ymgmr.2018.02.003","article-title":"Open-label clinical trial of bezafibrate in patients with fatty acid oxidation disorders in Japan","volume":"15","author":"Yamada","year":"2018","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"6","key":"10.1016\/j.mito.2024.101905_b0385","doi-asserted-by":"crossref","first-page":"e98972","DOI":"10.1371\/journal.pone.0098972","article-title":"Nicotinamide mononucleotide, an intermediate of NAD+ synthesis, protects the heart from ischemia and reperfusion","volume":"9","author":"Yamamoto","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.mito.2024.101905_b0390","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/hmg\/ddr482","article-title":"Effect of bezafibrate treatment on late-onset mitochondrial myopathy in mice","volume":"21","author":"Yatsuga","year":"2012","journal-title":"Hum. Mol. Genet."},{"issue":"7","key":"10.1016\/j.mito.2024.101905_b0395","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069282","article-title":"Primary respiratory chain disease causes tissue-specific dysregulation of the global transcriptome and nutrient-sensing signaling network","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.mito.2024.101905_b0400","doi-asserted-by":"crossref","first-page":"284","DOI":"10.7150\/ijbs.38487","article-title":"Nicotinamide riboside enhances mitochondrial proteostasis and adult neurogenesis through activation of mitochondrial unfolded protein response signaling in the brain of ALS SOD1G93A mice","volume":"16","author":"Zhou","year":"2020","journal-title":"Int. J. Biol. Sci."}],"container-title":["Mitochondrion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567724924000631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567724924000631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T18:31:29Z","timestamp":1732041089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567724924000631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":80,"alternative-id":["S1567724924000631"],"URL":"https:\/\/doi.org\/10.1016\/j.mito.2024.101905","relation":{},"ISSN":["1567-7249"],"issn-type":[{"value":"1567-7249","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ACAD9 treatment with bezafibrate and nicotinamide riboside temporarily stabilizes cardiomyopathy and lactic acidosis","name":"articletitle","label":"Article Title"},{"value":"Mitochondrion","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mito.2024.101905","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. and Mitochondria Research Society. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101905"}}